118 related articles for article (PubMed ID: 3770646)
1. Biocompatibility of various dialyzer membranes. The effects of the dialyzer membranes on the lymphocyte subpopulation during hemodialysis.
Miyazawa S; Morita T; Osaki K; Uemura S; Nakashima A; Harada R; Otsuji Y; Hashimoto S
Fukuoka Igaku Zasshi; 1986 Jul; 77(7):366-72. PubMed ID: 3770646
[No Abstract] [Full Text] [Related]
2. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
Strokov AG; Baeva LB; Levitskiĭ ER
Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
[TBL] [Abstract][Full Text] [Related]
3. Approach to dialysis biocompatibility: evaluation through in vivo investigation of lymphocyte biology. A technical note.
Stefoni S; Feliciangeli G; Nanni Costa A; Coli L; Cianciolo G; De Sanctis LB; Buscaroli A; Iannelli S; Mosconi G; Bonomini V
Contrib Nephrol; 1993; 103():65-75. PubMed ID: 8354064
[No Abstract] [Full Text] [Related]
4. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
Wauters JP
Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility in hemodialysis. Workshop on biocompatibility in hemodialysis, Bernried, March 18-20, 1982.
Contrib Nephrol; 1983; 36():1-138. PubMed ID: 6839764
[No Abstract] [Full Text] [Related]
7. Biocompatible membranes and hemodynamic tolerance to hemodialysis.
Branger B; Deschodt G; Oules R; Balducchi JP; Granolleras C; Alsabadani B; Fourcade J; Shaldon S
Kidney Int Suppl; 1988 Mar; 24():S196-7. PubMed ID: 3163048
[No Abstract] [Full Text] [Related]
8. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
[TBL] [Abstract][Full Text] [Related]
9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
11. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
Valeri A; Radhakrishnan J; Ryan R; Powell D
Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
[TBL] [Abstract][Full Text] [Related]
12. The hemodialysis membranes: a historical perspective, current state and future prospect.
Cheung AK; Leypoldt JK
Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
[TBL] [Abstract][Full Text] [Related]
13. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.
Götz AK; Böger CA; Popal M; Banas B; Krämer BK
Nephron Clin Pract; 2008; 109(3):c154-60. PubMed ID: 18663328
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
[No Abstract] [Full Text] [Related]
16. Biocompatibility of dialysis membrane.
Kes P
Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
[TBL] [Abstract][Full Text] [Related]
17. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
18. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
19. [Study on the effect of hemodialysis on lymphocyte subpopulation during dialysis].
Morita T
Fukuoka Igaku Zasshi; 1987 Apr; 78(4):129-36. PubMed ID: 3610013
[No Abstract] [Full Text] [Related]
20. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure].
Kes P; Sefer S
Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
